183 related articles for article (PubMed ID: 18707958)
21. Image-guided musculoskeletal biopsy.
Gogna A; Peh WC; Munk PL
Radiol Clin North Am; 2008 May; 46(3):455-73, v. PubMed ID: 18707957
[TBL] [Abstract][Full Text] [Related]
22. Integrated FDG-PET-CT: its role in the assessment of bone and soft tissue tumors.
Bischoff M; Bischoff G; Buck A; von Baer A; Pauls S; Scheffold F; Schultheiss M; Gebhard F; Reske SN
Arch Orthop Trauma Surg; 2010 Jul; 130(7):819-27. PubMed ID: 19636577
[TBL] [Abstract][Full Text] [Related]
23. [Value of dual-time-point (18)F-fluorodeoxyglucose integrated positron emission and computed tomography in differentiation of malignant from benign gastrointestinal diseases].
Xu XX; Cheng J; Xu WG; Dai D; Song XY; Ma WC; Zhu L; Zhu X
Zhonghua Zhong Liu Za Zhi; 2012 May; 34(5):364-8. PubMed ID: 22883458
[TBL] [Abstract][Full Text] [Related]
24. PET/CT in benign and malignant musculoskeletal tumors and tumor-like conditions.
Choi YY; Kim JY; Yang SO
Semin Musculoskelet Radiol; 2014 Apr; 18(2):133-48. PubMed ID: 24715446
[TBL] [Abstract][Full Text] [Related]
25. Positron emission tomography and bone metastases.
Fogelman I; Cook G; Israel O; Van der Wall H
Semin Nucl Med; 2005 Apr; 35(2):135-42. PubMed ID: 15765376
[TBL] [Abstract][Full Text] [Related]
26. Minimal invasive biopsy of intraconal expansion by PET/CT/MRI image-guided navigation: a new method.
Reinbacher KE; Pau M; Wallner J; Zemann W; Klein A; Gstettner C; Aigner RM; Feichtinger M
J Craniomaxillofac Surg; 2014 Oct; 42(7):1184-9. PubMed ID: 24726395
[TBL] [Abstract][Full Text] [Related]
27. Detection of bone metastases: assessment of integrated FDG PET/CT imaging.
Taira AV; Herfkens RJ; Gambhir SS; Quon A
Radiology; 2007 Apr; 243(1):204-11. PubMed ID: 17392254
[TBL] [Abstract][Full Text] [Related]
28. Utility of combined (18)F-fluorodeoxyglucose-positron emission tomography and computed tomography in patients with cervical metastases from unknown primary tumors.
Roh JL; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY
Oral Oncol; 2009 Mar; 45(3):218-24. PubMed ID: 18804404
[TBL] [Abstract][Full Text] [Related]
29. Whole body PET/CT for initial staging of choroidal melanoma.
Finger PT; Kurli M; Reddy S; Tena LB; Pavlick AC
Br J Ophthalmol; 2005 Oct; 89(10):1270-4. PubMed ID: 16170114
[TBL] [Abstract][Full Text] [Related]
30. 18F-FDG PET and PET/CT for detection of pulmonary metastases from musculoskeletal sarcomas.
Iagaru A; Chawla S; Menendez L; Conti PS
Nucl Med Commun; 2006 Oct; 27(10):795-802. PubMed ID: 16969262
[TBL] [Abstract][Full Text] [Related]
31. Musculoskeletal Pitfalls on Fluorodeoxyglucose F 18 PET-Computed Tomography: Pictorial Review.
Asadoorian M; Matcuk GR; Patel DB; Tomasian A; Wassef HR; White EA
PET Clin; 2018 Oct; 13(4):587-607. PubMed ID: 30219190
[TBL] [Abstract][Full Text] [Related]
32. Optimizing ultrasound-guided biopsy of musculoskeletal masses by application of an ultrasound contrast agent.
Loizides A; Widmann G; Freuis T; Peer S; Gruber H
Ultraschall Med; 2011 Jun; 32(3):307-10. PubMed ID: 20938892
[TBL] [Abstract][Full Text] [Related]
33. Whole body positron emission tomography/computed tomography staging of metastatic choroidal melanoma.
Kurli M; Reddy S; Tena LB; Pavlick AC; Finger PT
Am J Ophthalmol; 2005 Aug; 140(2):193-9. PubMed ID: 15992753
[TBL] [Abstract][Full Text] [Related]
34. The role of positron emission tomography in pediatric musculoskeletal oncology.
McCarville B
Skeletal Radiol; 2006 Aug; 35(8):553-4. PubMed ID: 16699780
[No Abstract] [Full Text] [Related]
35. Revisiting CT-guided percutaneous core needle biopsy of musculoskeletal lesions: contributors to biopsy success.
Omura MC; Motamedi K; UyBico S; Nelson SD; Seeger LL
AJR Am J Roentgenol; 2011 Aug; 197(2):457-61. PubMed ID: 21785094
[TBL] [Abstract][Full Text] [Related]
36. Can calcified pulmonary metastases detected by (18)F-FDG PET/CT suggest the primary tumor?
Hong CM; Ahn BC
Hell J Nucl Med; 2016; 19(1):10-2. PubMed ID: 27035906
[TBL] [Abstract][Full Text] [Related]
37. Hodgkin disease: diagnostic value of FDG PET/CT after first-line therapy--is biopsy of FDG-avid lesions still needed?
Schaefer NG; Taverna C; Strobel K; Wastl C; Kurrer M; Hany TF
Radiology; 2007 Jul; 244(1):257-62. PubMed ID: 17581905
[TBL] [Abstract][Full Text] [Related]
38. 18F-FDG PET/CT in the evaluation of POEMS syndrome.
Albertí MA; Martinez-Yélamos S; Fernandez A; Vidaller A; Narváez JA; Cano LM; Gamez C; Martinez-Matos JA
Eur J Radiol; 2010 Nov; 76(2):180-2. PubMed ID: 19581061
[TBL] [Abstract][Full Text] [Related]
39. Fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography imaging in patients with carcinoma of the nasopharynx: diagnostic accuracy and impact on clinical management.
Gordin A; Golz A; Daitzchman M; Keidar Z; Bar-Shalom R; Kuten A; Israel O
Int J Radiat Oncol Biol Phys; 2007 Jun; 68(2):370-6. PubMed ID: 17324532
[TBL] [Abstract][Full Text] [Related]
40. The hypermetabolic giant: 18F-FDG avid giant cell tumor identified on PET-CT.
O'Connor W; Quintana M; Smith S; Willis M; Renner J
J Radiol Case Rep; 2014 Jun; 8(6):27-38. PubMed ID: 25426232
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]